The sector fund Rhenman Healthcare Equity L\/S was named as a four-time winner at this
\nyear\u2019s Nordic Hedge Awards; best hedge fund of all Nordic hedge funds (of which there are
\n154), best Nordic equity hedge fund, and best-performing Nordic hedge fund for one and five
\nyears respectively.
\nThe awards were made in the categories ”Best Nordic Hedge Fund Overall 2017″, \u201cBest
\nNordic Equity Hedge Fund 2017”, ”Performance Award for 12 Months” and ”Performance
\nAward for 60 Months”.
\n”We are tremendously pleased over these awards. The Nordic Hedge Award is the most
\nprestigious Nordic award for hedge funds and a total of 154 funds were evaluated in 2017.
\nTo put it simply, this is the Nordic championship and for an equity hedge fund to win in four of
\nfive possible categories is a testament to our unique investment process which leads the
\nway, even internationally,” says Carl Grevelius, co-founder and head of investor relations.
\n”Our success depends largely on the fund managers’ many years of close collaboration with
\nthe medical experts in our Scientific Advisory Board. Equally important is our investment
\nteam’s single focus on the healthcare sector which includes
\npharmaceuticals, biotechnology, medical technology and service. This sectoral focus
\nprobably gives us a knowledge advantage compared to those investors who monitor
\nand invest in a number of sectors.\u201d
\nRhenman Healthcare Equity L\/S has an unprecedented performance history since its
\ninception in June 2009. The main fund class, the IC1 (EUR), has increased 426 percent in
\ntotal, which corresponds to an average annual return of 21 percent. In 2017, the fund
\ndelivered a return of 35 percent. At present, assets under management in the fund amount to
\napproximately 600 million EUR. In accordance with the fund\u2019s prospectus, the fund will close
\nfor new investments when its assets reach 1 billion EUR.
\nFor further information, please contact:
\nCarl Grevelius, Founding Partner \/ Head of Investor Relations
\nPhone: +46 8 459 88 83
\nEmail: carl@rhepa.com
\nwww.rhepa.com<\/p>\n
About Rhenman & Partners
\nRhenman & Partners Asset Management, founded in 2008, is a Stockholm-based asset
\nmanager focusing on two niche funds: Rhenman Healthcare Equity L\/S, launched in June
\n2009, and Rhenman Global Opportunities L\/S, launched in August 2016. Assets under
\nmanagement amount to approximately 600 MEUR. The management teams of the two funds
\nare supported in their respective investment processes by renowned advisors consisting of,
\namong others, eminent professors and experts with many years of market experience and
\nextensive expert networks around the world.<\/p>","protected":false},"excerpt":{"rendered":"
The sector fund Rhenman Healthcare Equity L\/S was named as a four-time winner at this year\u2019s Nordic Hedge Awards; best hedge fund of all Nordic hedge funds (of which there are 154), best Nordic equity hedge fund, and best-performing Nordic hedge fund for one and five years respectively. The awards were made in the categories […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"footnotes":""},"categories":[15],"tags":[],"class_list":["post-2076","post","type-post","status-publish","format-standard","hentry","category-rhenman-partners"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t